Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

International trends in anal cancer incidence rates
Farhad Islami, Jacques Ferlay, Joannie Lortet‐Tieulent, et al.
International Journal of Epidemiology (2016), pp. dyw276-dyw276
Open Access | Times Cited: 294

Showing 1-25 of 294 citing articles:

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
Farhad Islami, Ann Goding Sauer, Kimberly D. Miller, et al.
CA A Cancer Journal for Clinicians (2017) Vol. 68, Iss. 1, pp. 31-54
Open Access | Times Cited: 1378
Epidemiology and burden of HPV-related disease
Beatriz Serrano, María Brotons, F. Xavier Bosch, et al.
Best Practice & Research Clinical Obstetrics & Gynaecology (2017) Vol. 47, pp. 14-26
Closed Access | Times Cited: 486
Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Sheela Rao, Marianne G. Guren, Khurum Khan, et al.
Annals of Oncology (2021) Vol. 32, Iss. 9, pp. 1087-1100
Open Access | Times Cited: 172
Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58
Silvia de Sanjosé, Beatriz Serrano, Sara Tous, et al.
JNCI Cancer Spectrum (2018) Vol. 2, Iss. 4
Open Access | Times Cited: 170
Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies
Feixue Wei, Michael Gaisa, Gypsyamber D’Souza, et al.
The Lancet HIV (2021) Vol. 8, Iss. 9, pp. e531-e543
Open Access | Times Cited: 144
Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study
Leiwen Fu, Tian Tian, Kai Yao, et al.
JMIR Public Health and Surveillance (2022) Vol. 8, Iss. 7, pp. e34874-e34874
Open Access | Times Cited: 90
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study
Stéfano Kim, Éric François, Thierry André, et al.
The Lancet Oncology (2018) Vol. 19, Iss. 8, pp. 1094-1106
Closed Access | Times Cited: 124
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct
Sheela Rao, Francesco Sclafani, Cathy Eng, et al.
Journal of Clinical Oncology (2020) Vol. 38, Iss. 22, pp. 2510-2518
Open Access | Times Cited: 117
Anal cancer in high-income countries: Increasing burden of disease
Yoon‐Jung Kang, Megan A. Smith, Karen Canfell
PLoS ONE (2018) Vol. 13, Iss. 10, pp. e0205105-e0205105
Open Access | Times Cited: 114
Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis
Chunqing Lin, J Sláma, Paula González, et al.
The Lancet Infectious Diseases (2019) Vol. 19, Iss. 8, pp. 880-891
Open Access | Times Cited: 103
An overview of cancer health disparities: new approaches and insights and why they matter
Tsion Z. Minas, Maeve Kiely, Anuoluwapo Ajao, et al.
Carcinogenesis (2020) Vol. 42, Iss. 1, pp. 2-13
Open Access | Times Cited: 80
A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)
Sheela Rao, Gayathri Anandappa, Jaume Capdevila, et al.
ESMO Open (2022) Vol. 7, Iss. 4, pp. 100529-100529
Open Access | Times Cited: 53
Global burden of HPV‐attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: A worldwide analysis
Ashish A. Deshmukh, Haluk Damgacioglu, Damien Georges, et al.
International Journal of Cancer (2022) Vol. 152, Iss. 3, pp. 417-428
Open Access | Times Cited: 44
Anal Cancer: The Past, Present and Future
Talha Ashraf Gondal, Noman Chaudhary, Husnaat Bajwa, et al.
Current Oncology (2023) Vol. 30, Iss. 3, pp. 3232-3250
Open Access | Times Cited: 41
Anal Cancer Screening and Prevention: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Guidelines
Luis F. Barroso, Elizabeth A. Stier, Richard J. Hillman, et al.
Clinical Infectious Diseases (2022) Vol. 74, Iss. Supplement_2, pp. S179-S192
Closed Access | Times Cited: 39
Human Oncogenic Viruses: Characteristics and Prevention Strategies—Lessons Learned from Human Papillomaviruses
Luisa Galati, Maria Vincenza Chiantore, Mariarosaria Marinaro, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 416-416
Open Access | Times Cited: 17
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study
Stéfano Kim, François Ghiringhelli, Christelle de la Fouchardière, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 4, pp. 518-528
Open Access | Times Cited: 10
Anal Cancer Screening: 10-Year Experience of a Specialized Outpatient Clinic
Iolanda Espirito Santo, Amaniel Kefleyesus, Camille Chilou, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 193-193
Open Access | Times Cited: 1
Type-Specific Anal Human Papillomavirus Prevalence Among Men, According to Sexual Preference and HIV Status: A Systematic Literature Review and Meta-Analysis
Elske Marra, Chunqing Lin, Gary M. Clifford
The Journal of Infectious Diseases (2018) Vol. 219, Iss. 4, pp. 590-598
Open Access | Times Cited: 81
Long-term incidence trends of HPV-related cancers, and cases preventable by HPV vaccination: a registry-based study in Norway
Bo T. Hansen, Suzanne Hetzel Campbell, Mari Nygård
BMJ Open (2018) Vol. 8, Iss. 2, pp. e019005-e019005
Open Access | Times Cited: 68
A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus
Rebecca Fish, Caroline Sanders, Richard Adams, et al.
˜The œLancet. Gastroenterology & hepatology (2018) Vol. 3, Iss. 12, pp. 865-873
Open Access | Times Cited: 66
The changing landscape of cancer in the USA — opportunities for advancing prevention and treatment
Farhad Islami, Rebecca L. Siegel, Ahmedin Jemal
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 10, pp. 631-649
Closed Access | Times Cited: 52
Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study
Eric P. F. Chow, Sepehr N. Tabrizi, Christopher K. Fairley, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 10, pp. 1448-1457
Closed Access | Times Cited: 49
A Review of Chronic Comorbidities in Adults Living With HIV: State of the Science
Allison R. Webel, Julie Schexnayder, Patricia A. Cioe, et al.
Journal of the Association of Nurses in AIDS Care (2021) Vol. 32, Iss. 3, pp. 322-346
Open Access | Times Cited: 44
Global trends in anal cancer incidence and mortality
Silvia Mignozzi, Claudia Santucci, Matteo Malvezzi, et al.
European Journal of Cancer Prevention (2023) Vol. 33, Iss. 2, pp. 77-86
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top